Impact of the Early Benefit Assessment on A Pharmaceutical's Real Consumption in Germany
Value Health
.
2014 Nov;17(7):A416.
doi: 10.1016/j.jval.2014.08.1006.
Epub 2014 Oct 26.
Authors
W Kotowa
1
,
B Häussler
2
,
S Reindl
1
,
A Höer
2
Affiliations
1
IGES Institut GmbH, Nuremberg, Germany.
2
IGES Institut GmbH, Berlin, Germany.
PMID:
27201043
DOI:
10.1016/j.jval.2014.08.1006
No abstract available